Rang	Name	Position
1	Dr. Bassil I. Dahiyat Ph.D.	Co-Founder, CEO, President & Director
2	Mr. Bart Jan Cornelissen	Senior VP & CFO
3	Dr. John R. Desjarlais Ph.D.	Executive VP of Research & Chief Scientific Officer
4	Ms. Celia E. Eckert J.D.	Senior VP, General Counsel & Corporate Secretary
5	Mr. Charles Liles	Associate Director and Head of Corporate Communications & Investor Relations
6	Ms. Jennifer Sandoz	Senior VIce President of Human Resources
7	Mr. Kirk Rosemark RAC	Senior Vice President of Regulatory Affairs & Quality Assurance
8	Mr. Eric P. Kowack	Senior Vice President of Program Leadership & Alliance Management
9	Mr. Dane Vincent Leone C.F.A.	Executive VP & Chief Strategy Officer
10	Dr. Mark Osterman M.D.	Senior Vice President of Clinical Development (Autoimmune)

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	0,00%	0,00 Mio. USD
2	PRIMECAP Management Company	0,00%	0,00 Mio. USD
3	Vanguard Group Inc	0,00%	0,00 Mio. USD
4	Bvf Inc	0,00%	0,00 Mio. USD
5	RTW INVESTMENTS, LLC	0,00%	0,00 Mio. USD
6	RA Capital Management, LLC	0,00%	0,00 Mio. USD
7	State Street Corp	0,00%	0,00 Mio. USD
8	Vanguard Portfolio Management, LLC	0,00%	0,00 Mio. USD
9	Vanguard Capital Management, LLC	0,00%	0,00 Mio. USD
10	TCG Crossover Management, LLC	0,00%	0,00 Mio. USD
11	EcoR1 Capital, LLC	0,00%	0,00 Mio. USD
12	Geode Capital Management, LLC	0,00%	0,00 Mio. USD
13	T. Rowe Price Associates, Inc.	0,00%	0,00 Mio. USD
14	Morgan Stanley - Brokerage Accounts	0,00%	0,00 Mio. USD
15	Dimensional Fund Advisors, Inc.	0,00%	0,00 Mio. USD
16	Baker Bros Advisors LP	0,00%	0,00 Mio. USD
17	UBS Group AG	0,00%	0,00 Mio. USD
18	Legal & General Group PLC	0,00%	0,00 Mio. USD
19	Two Sigma Investments LLC	0,00%	0,00 Mio. USD
20	The Goldman Sachs Group Inc	0,00%	0,00 Mio. USD